This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Jarvis, S. C Search for Related Content Social Bookmarking                         What's this?

VALUE, blood pressure and diabetes — what can we learn?

Richford Gate Medical Practice, Richford Street, London, W6 7HY, UK, sarah.jarvis{at}gp-E85016.nhs.uk

With the introduction of the new GMS contract, GPs need to treat patients efficiently and effectively in order to achieve Quality and Outcomes Framework points. The VALUE trial has shown that aggressive treatment of hypertension minimises the risk of further cardiovascular outcomes. Dr Sarah Jarvis, a GP, notes that applying the results of this trial to clinical practice will help GPs reach their targets and protect hypertensive patients against further health risks such as new onset diabetes.

Key Words: VALUE trial • diabetes • hypertension • GMS contract.

The British Journal of Diabetes & Vascular Disease, Vol. 4, No. 6, 418-420 (2004)
DOI: 10.1177/14746514040040061001


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?